Conduit Pharmaceuticals Inc [NASDAQ: CDT] price surged by 83.87 percent to reach at $1.3.
CDT Stock Performance Analysis:
Conduit Pharmaceuticals Inc [CDT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 14.92. With this latest performance, CDT shares dropped by -69.68% in over the last four-week period, additionally sinking by -82.73% over the last 6 months – not to mention a drop of -99.01% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CDT stock in for the last two-week period is set at 38.55, with the RSI for the last a single of trading hit 40.02, and the three-weeks RSI is set at 38.87 for Conduit Pharmaceuticals Inc [CDT]. The present Moving Average for the last 50 days of trading for this stock 6.92, while it was recorded at 2.06 for the last single week of trading, and 72.13 for the last 200 days.
Insight into Conduit Pharmaceuticals Inc Fundamentals:
Conduit Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.12 and a Current Ratio set at 0.12.
Conduit Pharmaceuticals Inc [CDT] Institutonal Ownership Details
There are presently around $4.06%, or 7.97%% of CDT stock, in the hands of institutional investors.
